Centrally-mediated opioid-induced immunosuppression: Elucidation of sympathetic nervous system involvement

Advances in Experimental Medicine and Biology

Volumn 437, Issue , 1998, Pages 43-49

  Brinkman, William J ^a   Hall, David M ^a   Suo, Jin Liang ^a   Weber, Richard J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; MORPHINE; OPIATE;

ANTIBODY PRODUCTION; CELLULAR IMMUNITY; CONFERENCE PAPER; DRUG EFFECT; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NEUROIMMUNOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYMPATHETIC TONE;

EID: 0031877530     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5347-2_5     Document Type: Article

References (49)

1. Hussey, H.H. and Katz S., Infections resulting from narcotic addiction; report of 102 cases, American Journal of Medicine, 9,186, 1950.
2. Louria, D.B., Hensle, T., and Rose, J., The major medical complications of heroin addiction, Annals of Internal Medicine, 67,1, 1967.
3. Sapira, J.D. The narcotic addict as a medical patient, American Journal of Medicine., 45,555, 1968.
4. Brown, S.M., Stimmel, B., Taub, R.N., Kochwa, S., and Rosenfield, R.E., Immunologic dysfunction in heroin addicts, Archives of Internal Medicine, 134,1001, 1974.
5. Weber, R.J., Ikejiri, B., Rice, K.C., Pert, A., and Hagan, A., Opiate receptor mediated regulation of the immune response in vivo, NIDA Research Monograph., 76,341, 1987.
6. Dinari, G., Ashkenazi, S., Marcus, H., Rosenbach, Y. and Zahavi, I., The effect of opiates on the intestinal immune response to cholera toxin in mice, Digestion, 44,14, 1989.
7. Bryant, H.U., Berton, E.W. and Holaday J.W.., Immunomodulatory effects of chronic morphine treatment: pharmacologic and mechanistic studies, NIDA Res Mongr., 96,131, 1990a.
8. Molitar, T.W., Morilla A., Risdahl J.M., Murtaugh M.P., Chao C.C. and Peterson P.K., Chronic morphine administration impairs cell-mediated immune responses in swine, J Pharmacol Exp Ther., 260,581, 1992.
9. Bryant, H.U. and Roudebush, R.E., Suppressive effects of morphine pellet implants on in vivo parameters of immune function, J Pharmacol Exp Ther., 255,410, 1990b.
10. Lysle, D. T., Hoffman, K. E., and Dykstra, L. A., Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status, J. Pharmacol. Exp. Ther., 277,1533, 1996.
11. Fecho, K., Maslonek, K.A., Dykstra, L.A. and Lysle, D.T., Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats, J Pharmacol Exp Ther., 276,626, 1996b.
12. Scott, M. and Carr, D.J.J., Morphine suppresses the alloantigen-driven CTL response in a dose-dependent and naltrexone reversible manner, J. Pharmacol. Exp. Ther., 278,980, 1996.
13. Yeager, M.P., Colacchio, T.A., Yu, C.T., Hildebrandt, L., Howell, A.L., Weiss, J., Guyre, P.M., Morphine Inhibits Spontaneous and Cytokine enhanced Natural Killer Cell Cytotoxicity in Volunteers, Anesthesiology., 83,500, 1995.
14. Carr, D.J.J., Mayo, S., Gebhardt, B., and Porter, J., Central α-adrenergic involvement in morphine-mediated suppression of splenic natural killer activity, J. Neuroimmunol., 53,53, 1994.
15. Carr, D.J.J. and France, C. P., Immune alterations in morphine-treated Rhesus monkeys, J. Pharmacol. Exp. Ther., 267,9, 1993a.
16. Provinciali, M., Di Stefano, G., Rafaeli, W., Pari, G., Desiderio, F. and Fabris, N., Evaluation of NK and LAK cell activities in neoplastic patients during treatment with morphine, Int J Neurosci., 59,127, 1991.
17. Bayer, B.M., Daussin, S., Hernandez, M., and Irvin, L., Morphine inhibition of lymphocyte activity is mediated by an opioid-dependent mechanism, Neuropharmacology, 29,369, 1990a.
18. Weber, R.J. and A. Pert., The periaqueductal gray matter mediates opiate-induced immunosuppression, Science., 245,188, 1989.
19. Shavit, Y., Depaulis, A., Martin, F.C., Terman, G.W., Pechnick, R.N., Zane, C.J., Gale, R.P. and Liebeskind, J.C., Involvement of brain opiate receptors in the immune-suppressive effect of morphine, Proc Natl Acad Sci USA., 83, 7114, 1986.
20. Lysle, D.T., Coussons, M.E., Watts, V.J., Bennett, E.H. and Dykstra, L.A., Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone, J Pharmacol Exp Ther., 265,107, 1993.
21. Bayer, B. M., Mulroney, S. E., Hernandez, M. C., and Ding, X. Z., Acute infusions of cocaine result in time- and dose-dependent effects on lymphocyte responses and corticosterone secretion in rats, Immunopharmacology., 29,19, 1995.
22. Flores, L. R., Dretchen, K. L., and Bayer, B. M., Potential role of the autonomic nervous system in the immunosuppressive effects of acute morphine administration, Eur. J. Pharmacol., 318,437, 1996.
23. Suo, J. and Weber, R. J., Immunosuppression following PAG morphine injection is correlated with activation of the HPA axis and is not blocked by mifepristone, in Drugs of Abuse, Immunomodulation and AIDS, H. Friedman, J. Madden, and T. Klein, Eds., Plenum Publishing Corp, New York, NY 1997, in press.
24. Carr, D.J.J. and Carpenter, G. W., Morphine-induced suppression of cytotoxic T lymphocyte activity in alloimmunized mice is not mediated through a naltrindole-sensitive delta opioid receptor, Neuroimmunomodulation., 2,44, 1995.
25. Rojavin, M., Szabo, I., Bussiere, J.L., Rogers, T.J., Adler, M.W., and Eisenstein, T.K., Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages, Life Sci., 53,997, 1993.
26. Gomez-Flores, R. and Weber, R.J., Immunomodulation of macrophage functions by opioids, in Drugs of Abuse, Immunomodulation and AIDS, H. Friedman, J. Madden, and T. Klein, Eds., Plenum Publishing Corp, New York, NY 1997, in press.
27. Tubaro, E., Borelli, G., Croce, C., Cavallo, G. and Santiangeli, C., Effect of morphine on resistance to infection, J Infect Dis., 148,656, 1983.
28. Starec, M., Rouveix, B., Sinet, M., Chau, F., Desforges, B., Pocidalo, J.J., and Lechat, P., Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus, Journal of Pharmacology and Experimental Therapeutics., 259,745, 1991.
29. Chao, C.C., Sharp, B.M., Pomeroy, C., Filice, G.A., and Peterson, P.K., Lethality of morphine in mice infected with Toxoplasma gondii, Journal of Pharmacology and Experimental Therapeutics, 252,605, 1990.
30. Lewis, J.W., Shavit, Y., Terman, G.W., Gale, R.P. and Liebeskind, J.C., Stress and morphine affect survival of rats challenged with a mammary ascites tumor, Nat Immun Cell Growth Regul., 3,43, 1983.
31. Watson, R.R. and Nguyen, T.H., Suppression by morphine and ethanol of tumor cell cytotoxic activity released by macrophages from retrovirally infected mice upon in vitro stimulation by beta carotene, Prog Clin Biol Res., 325,79, 1990.
32. Weber, R.J. and Pert, A., Opiatergic modulation of the immune system, in Central and Peripheral Endorphins: Basic and Clinical Aspects, Muller and Genazzani, Eds., New York: Raven Press, 1984, p.35.
33. Hernandez, M.C., Flores, L.R., and Bayer, B.M., Immunosuppression by morphine is mediated by central pathways, The Journal of Pharmacology and Experimental Therapeutics., 267,1336, 1993.
34. Munck, A., Guyre, P.M., and Holbrook, H.J., Physiological functions of glucocorticoids in stress and their relations to pharmacological actions, Endocr Rev., 1,25, 1984.
35. Bayer, B.M., Hernandez, M. and Irvin L., Suppression of lymphocyte activity after acute morphine administration appears to be glucocorticoid independent, Alcohol Immunomodulation, and AIDS., 325,273, 1990b.
36. Felten, D.L., Felten, S.Y., Olschowka, J.A. and Livnat, S., Noradrenergic and peptidergic innervation of lymphoid tissue, J Immunol., 135,755s, 1985.
37. Felten, S.Y. and Olschowka, J.A., Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synapticlike contacts on lymphocytes in the splenic white pulp, J Neurosci Res., 18,37, 1987.
38. Fecho, K., Dykstra L.A. and Lysle, D.T., Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine, J Pharmacol Exp Ther., 265,1079, 1993a.
39. Weber, R.J. and Pert, A., Immune system, neural control, in Encyclopedia of neuroscience., 793, 1997.
40. Fecho, K., Maslonek, K.A., Dykstra, L.A. and Lysle, D.T., Alterations of immune status induced by the sympathetic nervous system: immunomodulatory effects of DMPP alone and in combination with morphine, Brain, Behavior, and Immunity., 7,253, 1993b.
41. Madden, K.S., Moynihan, J.A., Brenner, G.J., Felten, S.Y., Felten, D.L. and Livnat, S., Sympathetic nervous system modulation of the immune system III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy, J Neuroimmunol., 49,77, 1994.
42. Kruszewsda, B., Felten S.Y. and Moynihan, J.A., Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice, J. Immunol., 155,4613, 1995.
43. Schlesinger, Arevalo, L., M., Simon, V., Lopez, M., Munoz, C., Hernandez, A., Carreno, P., Belmar, J., White A. and Haffner-Cavaillon, N., Immune depression induced by protein calorie malnutrition can be suppressed by lesioning central noradrenaline systems, J Neuroimmunol., 57,1, 1995.
44. Delrue-Perollet, C., Li, K., Vitiello, S. and Neveu, P., Peripheral catecholamines are involved in the neuroendocrine and immune effects of LPS, Brain, Behavior, and Immunity., 9,149, 1995.
45. Fecho, K., Maslonek, K.A., Dykstra, L.A., and Lysle, D.T., Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats, J Pharmacol Exp Ther., 277,633, 1996a.
46. Williams W., Rice K.C., and Weber R.J. Nonpeptide opioids: in vivo effects on the immune system, National Institute of Drug Abuse Research Monograph., 105,404, 1991.
47. Band, L.C., Pert, A., Williams, W., de Costa, B.R., Rice, K.C., and Weber, R.J., Central u-opioid receptors mediate suppression of natural killer activity in vivo. Progress in Neuroendocrinimmunology., 5,95, 1992.
48. Carr, D.J., Gebhardt, B.M. and Paul, D., Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity, J Pharmacol Exp Ther., 264,1179, 1993b.
49. Kamei, J., Saitoh, A., Suzuki, T., Misawa, M., Nagase, H. and Kasuya, Y., Buprenorphine exerts its antinociceptive activity via mu1-opioid receptors, Life sciences., 56,285, 1995.